Ixodes cornuatus

From WikiMD's WELLNESSPEDIA

Ixodes cornuatus is a species of tick that is native to Australia. It is commonly known as the southern paralysis tick or common marsupial tick. This species is part of the Ixodidae family, which is the largest family of ticks globally.

Taxonomy[edit]

The Ixodes cornuatus was first described by Robert McLachlan in 1870. It belongs to the genus Ixodes, which is the largest genus of ticks and includes many species that are significant to human and animal health.

Distribution and habitat[edit]

Ixodes cornuatus is found primarily in the southeastern regions of Australia, including Tasmania, Victoria, and New South Wales. It inhabits a variety of environments, from coastal areas to forests and grasslands.

Life cycle[edit]

Like all ticks, Ixodes cornuatus goes through four stages in its life cycle: egg, larva, nymph, and adult. The tick feeds once at each stage before molting to the next, with the exception of adult males, which do not feed.

Medical significance[edit]

Ixodes cornuatus is known to be a vector for several diseases, including Lyme disease and Babesiosis. It can also cause tick paralysis, a potentially fatal condition that can affect both humans and animals.

Prevention and control[edit]

Prevention of tick bites is the most effective way to avoid the diseases transmitted by Ixodes cornuatus. This can be achieved through the use of repellents, wearing protective clothing, and checking for ticks after being in tick-infested areas. Control measures include the use of acaricides and habitat modification.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.